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Introduction {#ijpp12405-sec-0005}
============

Worldwide, the number of medicinal products that can be obtained over the counter, that is, purchased in pharmacies without a medical prescription, is growing.[1](#ijpp12405-bib-0001){ref-type="ref"} The reasons for this are that medicinal products that previously required a prescription are increasingly being removed from the list of prescription‐only medicinal products (OTC switch) along with patient preferences for taking greater responsibility for their own health.[2](#ijpp12405-bib-0002){ref-type="ref"} In Germany, for example, 72% of citizens indicate in a survey conducted by the Federal Union of German Associations of Pharmacists (ABDA) that for minor health issues they would first go to a pharmacy.[3](#ijpp12405-bib-0003){ref-type="ref"}

Of the approximately 100 000 medicinal products with marketing authorisation in Germany, about half belong to the over‐the‐counter medicinal products market segment.[4](#ijpp12405-bib-0004){ref-type="ref"} Even when measuring the share of sales in package units, this market segment still represents about half the share.[5](#ijpp12405-bib-0005){ref-type="ref"} Because these preparations are largely used for self‐medication, expert advice from the pharmacy is essential. Pharmacies can help to prevent risks resulting from improper use or at least significantly reduce these risks, because employees in the pharmacies should have extensive knowledge about the medications in terms of their effects, side effects and use.

Good advice is not only helpful for the customer or patient, but also plays a crucial role in competition between pharmacies. The freedom to establish pharmacies on the one hand and the increasing competition with mail‐order pharmacies in recent years on the other means that there is a brisk competitive environment in many areas of Germany. A good advisory service in this context is an important means of gaining a competitive edge.

Various studies available for Germany show that the quality of the advice provided to customers by pharmacies has considerable room for improvement.[6](#ijpp12405-bib-0006){ref-type="ref"}, [7](#ijpp12405-bib-0007){ref-type="ref"}, [8](#ijpp12405-bib-0008){ref-type="ref"}, [9](#ijpp12405-bib-0009){ref-type="ref"}, [10](#ijpp12405-bib-0010){ref-type="ref"} However, these studies refer to indications other than acute diarrhoea, meaning that publicly accessible studies on the quality of advice provided by pharmacies in Germany for this indication are not yet available. Acute diarrhoea is also quite an important indication because it is one of the most common medical conditions in Germany. About 41 million cases of acute diarrhoea can be assumed each year, about two‐thirds of which are treated without a medical consultation.[11](#ijpp12405-bib-0011){ref-type="ref"} If diarrhoea is treated by self‐medicating, those affected are commonly dependent on the advice by the pharmacy because acute diarrhoea can be a symptom of a wide range of medical conditions. It is therefore also necessary to query how the symptoms have progressed to take into account the duration, concomitant symptoms and the severity and, where necessary, to recommend the patient seek medical advice.[12](#ijpp12405-bib-0012){ref-type="ref"}

The primary aim of this study was to investigate the counselling practices of community pharmacies provided for acute diarrhoea using simulated patients. The secondary objective was to evaluate the role of the patient\'s approach and different user groups in determining the outcome of counselling.

Methods {#ijpp12405-sec-0006}
=======

Design {#ijpp12405-sec-0007}
------

The study used the 'simulated patient' method to determine the quality of advice provided by the pharmacies being assessed, a procedure that is a type of mystery shopping. This approach was used to assess the quality of services provided and is a type of participatory observation. The test buyers simulated an apparently real situation to participate in a service provision process. This was subsequently evaluated by the test buyers to reveal any possible deficiencies.[13](#ijpp12405-bib-0013){ref-type="ref"} The method is established internationally to determine the quality of advice provided by pharmacies.[14](#ijpp12405-bib-0014){ref-type="ref"}, [15](#ijpp12405-bib-0015){ref-type="ref"}, [16](#ijpp12405-bib-0016){ref-type="ref"}, [17](#ijpp12405-bib-0017){ref-type="ref"}, [18](#ijpp12405-bib-0018){ref-type="ref"}, [19](#ijpp12405-bib-0019){ref-type="ref"}

Five female Master students of a German University (University of Applied Sciences Neubrandenburg, Faculty of Health, Nursing, Administration) were selected to be the Simulated Patients. The selection process was based on their participation in a student research project in their first year of graduate studies in Health Sciences.

Setting and participation {#ijpp12405-sec-0008}
-------------------------

The test purchases were made between the start of May 2014 and the end of July 2014 in the city of Neubrandenburg (about 63 000 residents; located in the state of Mecklenburg‐Western Pomerania), which has 21 pharmacies in the city region.[20](#ijpp12405-bib-0020){ref-type="ref"} Each pharmacy was visited once using four different test scenarios, giving a total of 84 test purchases (4 scenarios × 1 visit × 21 pharmacies). When carrying out the individual test purchases, there was no differentiation made regarding the education of the pharmacy personnel providing the advice. A total of €375.87 was required to carry out these test purchases, a sum that was drawn from the resources of the primary author.

Outcomes and outcome measurements {#ijpp12405-sec-0009}
---------------------------------

According to work regulations for pharmacies, pharmacies in Germany are obliged to implement a quality management system that is intended to ensure a comprehensive advisory service.[21](#ijpp12405-bib-0021){ref-type="ref"} In this context, the German Federal Chamber of Pharmacists drafts a range of guidelines and working aids such as the document 'Information and advisory service as part of self‐medication using the example of self‐diagnosis of diarrhoea'.[12](#ijpp12405-bib-0012){ref-type="ref"} This formed the basis for the assessment form used in this study that is shown in Table [1](#ijpp12405-tbl-0001){ref-type="table"}. The assessment form only included 9 objective items that refer to the pharmacological advisory service in order to avoid a subjective evaluation and thus any latitude in the assessments made by the test buyers (such as the friendliness of the customer contact).[22](#ijpp12405-bib-0022){ref-type="ref"} For this reason, the individual items were only completed using dichotomous scales (closed yes/no questions). Weighting of the individual items was omitted because this in turn would depend on subjective considerations. To avoid influencing the quality of the advisory service provided by the pharmacies being tested and thus possibly a situation that no longer reflects reality (Hawthorne effect), the test purchases were covert; that is, they were conducted without informing the particular pharmacy beforehand, using a similar approach to some other international studies.[14](#ijpp12405-bib-0014){ref-type="ref"}

###### 

Assessment form

  Variables                                                                             Coding   
  ------------------------------------------------------------------------------------- -------- ---
  For whom is the medicinal product?                                                    0        1
  How long have the symptoms been present?                                              0        1
  How often do the symptoms occur?                                                      0        1
  What other symptoms are present?                                                      0        1
  Have the symptoms already been clarified by a doctor?                                 0        1
  Are other diseases present or what medicinal products are currently/regularly used?   0        1
  How does the medication have to be used?                                              0        1
  How long can/must the medication be taken?                                            0        1
  What side effects may occur?                                                          0        1
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Because there is clear evidence in the international literature of differences in the reporting quality between symptom‐based and medication‐based requests,[1](#ijpp12405-bib-0001){ref-type="ref"}, [6](#ijpp12405-bib-0006){ref-type="ref"}, [23](#ijpp12405-bib-0023){ref-type="ref"}, [24](#ijpp12405-bib-0024){ref-type="ref"} this study aimed to determine whether these differences also apply to the indication 'acute diarrhoea' in addition to determining pharmacies' compliance with the standard of advice required. For this reason, two of the scenarios were designed as medication based (test scenarios 1 and 3) and the other two were symptom based (test scenarios 2 and 4). In the first and third scenarios, the test buyers made a medication‐based enquiry about the active substance loperamide, which is most commonly provided by pharmacies in Germany for self‐medication of acute diarrhoea and is a component of various over‐the‐counter medicinal products.[25](#ijpp12405-bib-0025){ref-type="ref"} In contrast, in the second and fourth scenarios, the test buyers requested a medication to treat acute diarrhoea, making a symptom‐based enquiry.

We also intended to test whether the quality of the advisory service provided by pharmacies differed depending on whether the preparation requested was for an older person with underlying diseases or for a younger person with no underlying diseases. For this reason, the test buyers in the first and second scenarios made the request on behalf of their 74‐year‐old grandmother (with diabetes mellitus and hypertension as the underlying diseases), while in the third and fourth scenarios, the request was for a 30‐year‐old partner (with no underlying diseases). Otherwise, the information given to the pharmacy sales personnel in response to their questions was identical for each of the four test purchases (see Table [2](#ijpp12405-tbl-0002){ref-type="table"}).

###### 

Test scenarios

  *Scenario 1*
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  The test buyer enters the pharmacy and asks for a pack of loperamide. If the pharmacist offers a substitute preparation, the test buyer is willing to accept it. This is regardless of whether a medication with a different active substance or a homoeopathic preparation is offered
  If the pharmacist asks, the following information is supplied:
  Preparation is for the test buyer\'s 74‐year‐old grandmotherAcute diarrhoea present for 24 h and has occurred several times up to nowThe grandmother\'s fluid intake is adequate, no vomiting, no blood in the stool, no feverHas not yet visited a doctorUnderlying conditions: Diabetes and high blood pressure
  *Scenario 2*
  The test buyer enters the pharmacy and asks for a preparation to treat diarrhoea. The test buyer does not have any particular product in mind
  If the pharmacist asks, the following information is supplied:
  Preparation is for the test buyer\'s 74‐year‐old grandmotherAcute diarrhoea present for 24 h and has occurred several times up to nowThe grandmother\'s fluid intake is adequate, no vomiting, no blood in the stool, no feverHas not yet visited a doctorUnderlying conditions: Diabetes and high blood pressure
  *Scenario 3*
  The test buyer enters the pharmacy and asks for a pack of loperamide. If the pharmacist offers a substitute preparation, the test buyer is willing to accept it. This is regardless of whether a medication with a different active substance or a homoeopathic preparation is offered
  If the pharmacist asks, the following information is supplied:
  Preparation is the test buyer\'s 30‐year‐old partnerAcute diarrhoea present for 24 h and has occurred several times up to nowThe partner\'s fluid intake is adequate, no vomiting, no blood in the stool, no feverHas not yet visited a doctorNo underlying conditions
  *Scenario 4*
  The test buyer enters the pharmacy and asks for a preparation to treat diarrhoea. The test buyer does not have any particular product in mind
  If the pharmacist asks, the following information is supplied:
  Preparation is the test buyer\'s 30‐year‐old partnerAcute diarrhoea present for 24 h and has occurred several times up to nowThe partner\'s fluid intake is adequate, no vomiting, no blood in the stool, no feverHas not yet visited a doctorNo underlying conditions
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Data collection {#ijpp12405-sec-0010}
---------------

The test buys in each scenario were made at 2‐week intervals. There was 1 week between each of the individual scenarios (with 21 test purchases each). The pharmacies to be tested were allocated randomly to the particular test buyers in the first step. As a result, each test buyer was allocated a total of 16--18 test purchases across all the scenarios. After the allocation but before the visits, we subsequently checked and ensured that none of the pharmacies were visited multiple times by any one test buyer to prevent the risk of the test buyers being exposed. This produced an overview of which test buyers visited which pharmacy using which scenario at what time. Before data collection was started, each test buyer carried out four pretests outside Neubrandenburg for each of the four scenarios. The functionality of the assessment form and the four test scenarios was confirmed in the process.

For data privacy reasons, audio recordings were not adopted. However, the assessment forms were completed by the test buyers immediately after visiting the pharmacies so that recall bias by the test buyers could be minimised.

After evaluating the data collection, each pharmacy was given individual performance feedback in which the particular pharmacy was assessed relative to the other anonymised competitors in the city of Neubrandenburg using benchmarking. This gave the pharmacies information about their competitive position so that ideally the pharmacies visited could implement appropriate optimisation processes based on this information with the aim of sustainably improving the quality of their advisory service.

Data management and analysis {#ijpp12405-sec-0011}
----------------------------

The statistical software program SPSS 22 was used to record and analyse the data. Items were scored dichotomously (0 = variable not met, 1 = variable met). The data obtained were initially analysed using descriptive statistics. To investigate whether there were significant effects on the counselling quality due to the type of request (product versus symptom‐based request), different user groups (74‐year‐old grandmother with diabetes mellitus and hypertension versus 30‐year‐old partner with no underlying diseases) and the interaction between the type of request and different types of user groups, a mixed model ANOVA was carried out. In this model, each community pharmacy served as a level of a random factor while request and user group both served as fixed factors. Results were considered statistically significant if *P* values were less than 0.05.

Ethical approval {#ijpp12405-sec-0012}
----------------

Following the 'Guideline for the use of mystery research in market and social research',[26](#ijpp12405-bib-0026){ref-type="ref"} the information obtained was recorded so that the pharmacists involved could not be identified and the results were reported anonymously. The study was approved retrospectively by the local University ethics committee, which was established after the study had commenced.

Results {#ijpp12405-sec-0013}
=======

All 84 planned simulated patient visits were completed. At the level of the individual variables, assessing 21 pharmacies produced a mean score of 7.7 of a possible 21 points (37%) across all test scenarios. The mean scores varied greatly between 0.8 points (4%) for the advice provided about side effects and 18.3 points (87%) for the advice provided about dosage. The advice provided about duration and the question 'for whom' also achieved relatively high mean scores of 14.0 points (67%) and 13.0 points (62%), respectively, whereas, for example, the questions asked about 'diseases' and 'clarification by a doctor' achieved relatively low mean scores of 1.5 points (7%) and 3.8 points (18%), respectively (see Table [3](#ijpp12405-tbl-0003){ref-type="table"}).

###### 

Assessment at variable level

                               Scenario 1   Scenario 2   Scenario 3   Scenario 4   Mean   Percentage
  ---------------------------- ------------ ------------ ------------ ------------ ------ ------------
  For whom?                    5            16           12           19           13.0   62
  For how long?                4            14           5            9            8.0    38
  How often?                   0            9            3            5            4.3    20
  Concomitant symptoms?        0            9            6            8            5.8    27
  Clarification by a doctor?   1            8            2            4            3.8    18
  Diseases?                    0            3            0            3            1.5    7
  Dosage                       17           21           16           19           18.3   87
  Duration                     15           15           9            17           14.0   67
  Side effects                 0            0            2            1            0.8    4
  Mean                         4.7          10.6         6.1          9.4          7.7    37
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At the level of the pharmacy, across the total of 9 variables on the assessment form and the dichotomous coding for each test scenario, each pharmacy obtained a result between 0 points (minimum) and 9 points (maximum). Across all four test scenarios, a mean score of 3.3 of a possible 9 points (37%) was achieved. The mean scores achieved varied greatly between 1.0 points (11%) and 5.0 points (56%) (see Table [4](#ijpp12405-tbl-0004){ref-type="table"}). The main effect was seen when comparing product and symptom requests (*F*(1,60) = 24.748, *P* \< 0.001, ω~p~ ^2^ = 0.277). Symptom‐based requests had a mean score of 4.3 of a possible 9 points (48%) compared to direct product requests with a mean score of 2.3 of a possible 9 points (26%). For the medication‐based enquiries, the advice received was accordingly considerably worse than for scenarios that did not involve a direct request for the active substance loperamide.

###### 

Assessment at pharmacy level

                Scenario 1   Scenario 2   Scenario 3   Scenario 4   Mean   Percentage
  ------------- ------------ ------------ ------------ ------------ ------ ------------
  Pharmacy 1    3            4            6            4            4.3    47
  Pharmacy 2    3            7            3            7            5.0    56
  Pharmacy 3    0            4            2            8            3.5    39
  Pharmacy 4    2            2            6            2            3.0    33
  Pharmacy 5    2            5            6            4            4.3    47
  Pharmacy 6    4            5            0            7            4.0    44
  Pharmacy 7    1            5            1            6            3.3    36
  Pharmacy 8    4            3            2            6            3.8    42
  Pharmacy 9    1            1            1            1            1.0    11
  Pharmacy 10   2            5            1            3            2.8    31
  Pharmacy 11   3            6            3            4            4.0    44
  Pharmacy 12   2            5            2            1            2.5    28
  Pharmacy 13   2            5            6            4            4.3    47
  Pharmacy 14   3            6            3            6            4.5    50
  Pharmacy 15   2            6            0            3            2.8    31
  Pharmacy 16   2            7            0            4            3.3    36
  Pharmacy 17   0            1            1            4            1.5    17
  Pharmacy 18   0            7            2            2            2.8    31
  Pharmacy 19   2            4            0            1            1.8    19
  Pharmacy 20   0            1            4            5            2.5    28
  Pharmacy 21   4            6            6            3            4.8    53
  Mean          2.0          4.5          2.6          4.0          3.3    37
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In terms of the question of whether the advice provided differed for the different user groups, in all four scenarios those pharmacies in which the variable 'For whom is the medication?' had a value of zero were first extracted. This enabled the data to be filtered for those pharmacies that knew who the particular user of the medication would be (see supporting information Data [S1](#ijpp12405-sup-0001){ref-type="supplementary-material"} and Table [S1](#ijpp12405-sup-0002){ref-type="supplementary-material"}).

There was no effect associated with the user group (*F*(1,28) = 0.237, *P* = 0.630, ω~p~ ^2^ = −0.026). Requests for a 74‐year‐old grandmother with underlying diseases had a mean score of 5.0 of a possible 9 points (56%), whereas requests for a 30‐year‐old partner with no underlying diseases had a mean score of 4.2 of a possible 9 points (47%).

There was no interaction between the type of request and the different user groups (*F*(1,28) = 3.395, *P* = 0.076, ω~p~ ^2^ = 0.073). The symptom‐based requests for the grandmother had a mean score of 5.4 of a possible 9 points (60%) compared to symptom‐based requests for the partner with a mean score of 4.3 of a possible 9 points (48%). The medication‐based requests for the grandmother achieved a mean score of 3.6 of a possible 9 points (40%) compared to medication‐based requests for the partner with a mean score of 3.9 of a possible 9 points (43%).

Discussion {#ijpp12405-sec-0014}
==========

The results of the present study made clear that the quality of advice provided for acute diarrhoea in adults in a north‐eastern German city was poor. The most common information provided was about dosage, while the least common information given was about side effects. Significant differences were seen when comparing the product and symptom requests, but there was no effect resulting from different user groups and no interaction between the type of request and different user groups.

This study was limited by the fact that it only investigated the quality of advice provided by pharmacies in a medium‐sized regional city in a particular region in Germany. It would therefore be useful if future studies are (ideally) based on an adequately large, randomised sample of pharmacies drawn from across Germany. It must also be noted as a further limitation that only four test purchases were carried out in each pharmacy. It would therefore be plausible to increase the number of test purchases per pharmacy for future studies.

Because it cannot be ruled out that the test results varied depending on the particular test buyers used, it is also possible that evaluations by other test buyers would lead to different results. On the other hand, using only objective items avoided possible leeway in the assessments made by the test buyers. This may have led to an increased reliability, but at the expense of validity. For example, pharmacy staff can ask questions in a great variety of quality, and reducing these to binary items conceals that real variability.

When carrying out the individual test purchases, there was no differentiation made regarding the education of the pharmacy personnel providing the advice. Therefore, it was not possible to determine whether there are significant differences in the advice provided by pharmacists and pharmaceutical technical assistants. Future studies should take this aspect into account, especially as there are contradictory study results in the international literature in this regard.[7](#ijpp12405-bib-0007){ref-type="ref"}, [23](#ijpp12405-bib-0023){ref-type="ref"}, [27](#ijpp12405-bib-0027){ref-type="ref"}, [28](#ijpp12405-bib-0028){ref-type="ref"}, [29](#ijpp12405-bib-0029){ref-type="ref"}

In this study, clear potential was found for almost all Neubrandenburg pharmacies to optimise the quality of advice provided for acute diarrhoea in adults. Similar problems are also described in a recent Turkish study.[27](#ijpp12405-bib-0027){ref-type="ref"}

Although the advice dispensed was only tested for the indication acute diarrhoea, other scientific studies in Germany of other indications (such as headaches) reveal that there is considerable room for improvement.[6](#ijpp12405-bib-0006){ref-type="ref"}, [7](#ijpp12405-bib-0007){ref-type="ref"} Stiftung Warentest, a consumer organisation in Germany, also conducts test purchases at regular intervals and identifies a rather poor quality advisory service.[8](#ijpp12405-bib-0008){ref-type="ref"}, [10](#ijpp12405-bib-0010){ref-type="ref"} This is in no way a problem limited to Germany because such deficiencies in the advice provided in pharmacies are described many times in the international literature.[23](#ijpp12405-bib-0023){ref-type="ref"}, [29](#ijpp12405-bib-0029){ref-type="ref"}, [30](#ijpp12405-bib-0030){ref-type="ref"}, [31](#ijpp12405-bib-0031){ref-type="ref"}, [32](#ijpp12405-bib-0032){ref-type="ref"}, [33](#ijpp12405-bib-0033){ref-type="ref"}, [34](#ijpp12405-bib-0034){ref-type="ref"}, [35](#ijpp12405-bib-0035){ref-type="ref"}, [36](#ijpp12405-bib-0036){ref-type="ref"}, [37](#ijpp12405-bib-0037){ref-type="ref"}, [38](#ijpp12405-bib-0038){ref-type="ref"} On the other hand, there are also a few examples internationally of in part appropriate advisory services provided by pharmacies.[39](#ijpp12405-bib-0039){ref-type="ref"}, [40](#ijpp12405-bib-0040){ref-type="ref"}

Depending on the particular criteria investigated, there were clear differences apparent in the quality of the advice provided. While, for example, barely any information was provided for the criterion 'side effects', pharmacies often provided information about the dosage of the medication. Similar differences are also seen in the international literature.[6](#ijpp12405-bib-0006){ref-type="ref"}, [7](#ijpp12405-bib-0007){ref-type="ref"}, [16](#ijpp12405-bib-0016){ref-type="ref"}, [28](#ijpp12405-bib-0028){ref-type="ref"}, [30](#ijpp12405-bib-0030){ref-type="ref"}, [31](#ijpp12405-bib-0031){ref-type="ref"}, [41](#ijpp12405-bib-0041){ref-type="ref"}, [42](#ijpp12405-bib-0042){ref-type="ref"}

What was noticeable was that barely any information was requested about the medication history or any existing medical conditions, even though certain medications can cause diarrhoea.[43](#ijpp12405-bib-0043){ref-type="ref"} In a Turkish study using simulated patients, the question of medication history was not asked in a single test purchase for acute diarrhoea in an adult.[27](#ijpp12405-bib-0027){ref-type="ref"} In a study using self‐assessment that was conducted in India, only 2% of the pharmacists surveyed indicate that they specifically ask about the medication history for acute diarrhoea in adults.[44](#ijpp12405-bib-0044){ref-type="ref"}

Questions about the duration or the frequency of the acute diarrhoea were only asked by a little more than one‐third or about one‐fifth of the pharmacy personnel, respectively. The results are even worse in the comparable Turkish study in which these questions are only asked in 18% and 9% of all test purchases, respectively.[27](#ijpp12405-bib-0027){ref-type="ref"} In comparison, in the study based on self‐assessment from India, 90% of the pharmacists surveyed indicate that they specifically ask questions about the duration for acute diarrhoea in adults.[44](#ijpp12405-bib-0044){ref-type="ref"}

Analogous to other national and international studies,[1](#ijpp12405-bib-0001){ref-type="ref"}, [6](#ijpp12405-bib-0006){ref-type="ref"}, [23](#ijpp12405-bib-0023){ref-type="ref"}, [24](#ijpp12405-bib-0024){ref-type="ref"}, [29](#ijpp12405-bib-0029){ref-type="ref"}, [45](#ijpp12405-bib-0045){ref-type="ref"} significant differences were confirmed between symptom‐based and medication‐based enquiries. In this respect, it would be important to make pharmacies or their staff more aware of the need to provide advice, particularly for medication‐based enquiries, for example, using training. Appropriate training materials are also a prerequisite for an adequate advisory service. During pharmacy studies, patient and customer consultations can be more intensively trained and evaluated using examples to refine the skills for providing advice, particularly as the teaching of 'soft skills' of this nature is below average in German universities to date.[46](#ijpp12405-bib-0046){ref-type="ref"}

Conclusions {#ijpp12405-sec-0015}
===========

This study was the first of its kind to investigate the quality of advice provided by pharmacies in Germany for acute diarrhoea in adults. Significant deficits were identified. Covert test purchases as part of a 'simulated patient' approach are a well‐tested means of revealing any weak points. However, they remain ineffective if the deficits that are identified are not communicated to the pharmacies and if the pharmacies do not subsequently implement appropriate improvement measures. Implementing the latter (comprehensively) is the key challenge facing pharmacists or their professional associations on the journey to providing better advice to customers and patients.
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